Atopic Dermatitis Market: Current Analysis and Forecast (2023-2030)

Report Description

The global Atopic dermatitis market was valued at USD 6,720.4 million in 2022 and is expected to grow a CAGR of 11.2% during the forecast period (2023-2030). Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin condition characterized by red, itchy, and inflamed patches of skin. It is a common condition that typically begins in infancy or childhood but can persist into adulthood. AD is believed to result from a combination of genetic, immune, and environmental factors, including defects in the skin barrier, immune system dysregulation, and exposure to allergens or irritants. Atopic dermatitis is a widespread chronic inflammatory skin condition, with its prevalence increasing globally, particularly in industrialized nations is boosting the atopic dermatitis(AD) market. For instance, According to the World Allergy Organization (WAO), AD prevalence ranges from 15% to 30% in children and 2% to 10% in adults globally. Moreover, with increasing healthcare expenditure worldwide, patients have greater access to healthcare services and treatments for chronic conditions like atopic dermatitis. For instance, According to a study published in JAMA Dermatology, the annual cost of atopic dermatitis in the United States exceeded $5.3 billion in 2018, with the majority of costs attributed to prescription medications and outpatient visits.

Some of the major players operating in the market are Pfizer Inc., Abbvie Inc., Bristol Myers Squibb, Regeneron Pharmaceuticals, Inc., Evelo Biosciences, Inc., Sanofi, Novartis AG, GALDERMA LABORATORIES, L.P., Eli Lilly and Company (Dermira), Otsuka Pharmaceutical Co., Ltd. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst Drug Class, the corticosteroids segment held a significant share of the market in 2023.”

Based on the Drug Class, the market has been categorized into corticosteroids, pde4 inhibitors, calcineurin inhibitors, skin barrier emollients, others. Among them, the corticosteroids segment is expected to grow at a higher CAGR in the market due to several factors, including its well-established efficacy in managing inflammation and itching associated with AD, its widespread availability, and its relatively low cost compared to some newer treatment options. Corticosteroids, whether topical or systemic, have long been a mainstay in the treatment of AD, offering rapid relief of symptoms and helping to control flare-ups. As a result, they remain a popular choice among healthcare providers and patients for the management of mild to moderate AD and as adjunctive therapy in more severe cases.

“Amongst end-user, the hospital pharmacies segment held the higher CAGR in the market in 2023.”

Based on the end-user, the market has been categorized into hospital pharmacies, retail pharmacies, online pharmacies. Among them, the hospital pharmacies category is to witness higher adoption of atopic dermatitis during the forecast period. The hospital pharmacy segment is experiencing growth in the atopic dermatitis (AD) market due to several factors, including the increasing prevalence of AD, the emergence of new treatment options, and the rising demand for specialized care in hospital settings. Hospitals play a crucial role in the management of AD, particularly in cases of severe disease requiring intensive therapy, multidisciplinary care, or access to advanced treatment modalities. Pharmaceutical companies continue to develop and introduce new treatment options for AD, including biologics, small molecule inhibitors, and novel topical formulations. Moreover, hospital pharmacies may offer specialized compounding services to tailor medications to the specific needs of AD patients.

“North America dominated the Atopic dermatitis market in 2023.”

The North America atopic dermatitis market is expected to continue to grow in the coming years, driven by the increasing prevalence of atopic eczema and growing awareness of atopic dermatitis among the general population, change in lifestyle. For instance, in 2020, according to national eczema.org, 31.6 million people (10.1%) in the U.S. have some form of eczema, and prevalence peaks during early childhood. It is estimated that 1 in 10 individuals will develop eczema during their lifetime, with prevalence peaking in early childhood.

Atopic dermatitis Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global Atopic dermatitis market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Atopic Dermatitis Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global Atopic dermatitis market were the three major steps undertaken to create and analyze the adoption of Atopic dermatitis in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Atopic dermatitis market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Atopic dermatitis market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Atopic dermatitis market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as drug class, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Atopic dermatitis market. Further, we conducted factor analysis using dependent and independent variables such as drug class, and end-user of the Atopic dermatitis market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Atopic dermatitis market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Atopic dermatitis market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the Atopic dermatitis market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global Atopic dermatitis market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Atopic dermatitis market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of drug class, and end-user in the global Atopic dermatitis market.

The main objective of the Global Atopic dermatitis Market Study

The current & future market trends of the global Atopic dermatitis market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the Atopic dermatitis market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of the drug class, and end-user
• Define and analysis of the regulatory framework for the Atopic dermatitis industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the Atopic dermatitis market for the major region
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the Atopic dermatitis market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team